Immuneering Corp
What this means
- Net loss in 2025Net loss of $56M for the year (2024: −$61M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$56M | −$61M |
| Total assets | $232M | $52.7M |
| Total liabilities | $13.5M | $11.3M |
| Stockholders’ equity | $218M | $41.4M |
| Cash and equivalents | $129M | $36.1M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Immuneering Corp
- CIK
- 0001790340
- Tickers
- IMRX
- Kind of filer
- SEC-reporting company
Emerging growth company - Status
- Filing with the SEC
- State of incorporation
- Delaware
- Business address
- Cambridge, Massachusetts
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Oct 29, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 8-K · items 5.02 · filed Nov 9, 2026 · filing
- Form 10-Q · filed Oct 29, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Oct 29, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 5, 2026 · filing
- Form 10-Q · filed Aug 5, 2026 · filing
- Form 8-K · items 5.02 · filed Jun 15, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 15, 2026 · filing
- Form 10-Q · filed May 15, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 6, 2026 · filing
- Form 10-K · filed Mar 6, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 12, 2025 · filing
- Form 10-Q · filed Nov 12, 2025 · filing
- Form D · items 06b · filed Sep 9, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 13, 2025 · filing
- Form 10-Q · filed Aug 13, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 5, 2025 · filing
- Form 10-Q · filed May 5, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 20, 2025 · filing
- Form 10-K · filed Mar 20, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 13, 2024 · filing
- Form 10-Q · filed Nov 13, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 6, 2024 · filing
- Form 10-Q · filed Aug 6, 2024 · filing
- Form 8-K · items 5.02 · filed May 23, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 7, 2024 · filing
- Form 10-Q · filed May 7, 2024 · filing
- Form 8-K · items 5.02, 8.01 · filed Mar 14, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 1, 2024 · filing
- Form 10-K · filed Mar 1, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 9, 2023 · filing
- Form 10-Q · filed Nov 9, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 3, 2023 · filing
- Form 10-Q · filed Aug 3, 2023 · filing
- Form 8-K · items 5.02 · filed Jun 14, 2023 · filing
- Form 10-Q · filed May 4, 2023 · filing
- Form 8-K · items 2.02, 7.01, 8.01, 9.01 · filed Apr 18, 2023 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Mar 6, 2023 · filing
- Form 10-K · filed Mar 6, 2023 · filing